Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis
Arthritis & Rheumatism, 08/07/09
van der Linden MPM et al. – Study suggests that for clinical practice, a single autoantibody test (out of anti-CCP-2, anti-CCP-3, anti-MCV, and RF) is sufficient for risk estimation in undifferentiated arthritis (UA) and rheumatoid arthritis (RA).
Methods- An evaluation of the capability of all autoantibodies and combinations of them to predict 3 outcome measures in RA:
- Progression from UA to RA
- Rate of joint destruction in RA, and
- Chance of achieving sustained DMARD-free remission
- Pts with UA (n=625) were studied for whether UA progressed to RA after 1 yr
- Pts with RA (n=687) were studied for:
- Whether sustained DMARD-free remission was achieved, and
- For the rate of joint destruction during a median f/u of 5 yrs
- Positive predictive values (PPVs) for RA development and for associations with the disease course in RA were compared between single tests and combinations of these tests
- Among the single tests for UA: anti-CCP-2 had highest PPV for RA development but the 95% CI of the other tests overlapped
- Among the single tests for RA: all 4 tests showed comparable associations with the rate of joint destruction and with the achievement of remission
- In both ACPA-positive and ACPA-negative RA, the presence of RF was not associated with more joint destruction
- For all outcome measures, performing combinations of 2 or 3 autoantibody tests did not increase the predictive accuracy vs a single test
Related Articles
Diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody for rheumatoid arthritis
Rheumatology International, 10/21/09
Relevance Score: 93%
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 90%
Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In Rheumatoid Arthritis Patients, Study Finds
ScienceDaily, 10/30/09
Relevance Score: 90%
Significance of anti-CCP antibodies in modification of 1987 ACR classification criteria in diagnosis of rheumatoid arthritis
Clinical Rheumatology, 10/21/09
Relevance Score: 90%
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
Arthritis Research & Therapy, 10/20/09
Relevance Score: 90%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Low cortisol levels in active juvenile idiopathic arthritis
Clinical Rheumatology, 12/20/09
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Rheumatology, 12/20/09
The 'RASor's' edge: Ras proteins and matrix destruction in arthritis
Arthritis Research & Therapy, 12/19/09
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Low cortisol levels in active juvenile idiopathic arthritis
Clinical Rheumatology, 12/20/09
Mean platelet volume in psoriasis and psoriatic arthritis
Clinical Rheumatology, 12/20/09
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Rheumatology, 12/20/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Low cortisol levels in active juvenile idiopathic arthritis
Clinical Rheumatology, 12/20/09
Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study
Arthritis Research & Therapy, 12/20/09
Update on the genetic risk factors for rheumatoid arthritis
Expert Review of Clinical Immunology, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


